Humacyte Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -14.2% | +25.9% | -14.4% | -17.0% | +20.1% | +17.9% | -14.6% | -34.1% | +27.2% | -5.0% | +24.9% | |
| – | -19.0% | +41.6% | -18.5% | -76.1% | +108.0% | +54.0% | -29.8% | -20.1% | +64.0% | -6.2% | +45.9% | |
| – | -19.5% | +43.6% | -19.0% | -78.0% | +118.4% | +39.9% | -39.5% | -48.8% | +159.1% | -3.9% | +64.6% | |
| – | -19.5% | +43.6% | -19.0% | -78.0% | +118.4% | +39.9% | -39.5% | -48.8% | +159.1% | -3.9% | +64.6% | |
| – | – | – | – | – | – | – | -19.3% | +173.6% | -59.1% | -1.6% | -24.0% | |
| – | – | – | – | – | – | – | +38.0% | +66.4% | -26.2% | -27.0% | -29.6% | |
| – | +2.0% | +18.0% | +23.1% | +7.2% | +6.8% | -33.6% | +6.5% | -28.6% | +17.7% | -12.6% | +8.0% | |
| – | +21.8% | -23.6% | +26.1% | +17.9% | -4.7% | +0.4% | +5.3% | +21.3% | -28.2% | -11.9% | -7.7% | |
| – | +3.2% | +4.0% | +3.1% | +3.1% | +1.0% | +3.1% | +73.3% | -48.7% | -9.1% | +0.0% | -37.5% | |
| – | +115.0% | -46.8% | +74.0% | +15.0% | -35.0% | +24.1% | +19.0% | +44.4% | -43.6% | -6.0% | -18.2% | |
| – | +3.5% | – | – | – | – | – | – | – | – | +1.2% | +1.3% | |
| – | -63.4% | +93.1% | -208.2% | – | – | – | -88.8% | -217.3% | – | +273.9% | +168.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +4.5% | +10.1% | +0.2% | -0.8% | +11.2% | +18.0% | +1.9% | -0.1% | +25.1% | +18.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.